ÂÜÀòÂÒÂ×

Chih-Chao Yang has an extensive background in biomedical sciences and extensive experience in various research roles. From their time as a Research Assistant at Academia Sinica to their current position as a Senior Scientist II at GC Therapeutics, Chih-Chao has focused on utilizing CRISPR/Cas9 technology for gene editing and cell line development. Chih-Chao has a strong track record of project management, team leadership, and delivering results in a timely manner. Chih-Chao's educational background includes a Ph.D. in Biomedical Sciences from The University of Texas Health Science Center at Houston.